Drugs / Nasal Guide
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 4 | NCT05918406 Background | Jun → Aug 2023 | dry eye syndrome | Oyster Point Pharma, Inc. | Completed | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Nasal Guide | ClinicalTrials.gov intervention name — accepted as the source's own label NCT05918406 ↗ |